Pentadecapeptide BPC (Oral)
aka Oral BPC-157
Healing & Recovery
Mechanism
Oral BPC-157 refers to stabilized oral preparations of the pentadecapeptide Body Protection Compound-157 (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), most commonly the arginate salt (sometimes acetate or enteric-coated capsules), intended to survive gastric transit and improve absorption versus the unformulated peptide. This entry covers the salt/stabilized formulations specifically; generic BPC-157 capsules without a salt-form claim are classified under the base BPC-157 entry.
Identification
| CAS number | 137525-51-0 |
|---|---|
| Molecular formula | C62H98N16O22 |
| Sequence | GEPPPGKPADDAGLV |
| Typical dose | 250–500 mcg/day orally (1–2x daily), taken on an empty stomach; research use only |
| Half-life | <30 minutes (preclinical IV/IM data in rats and dogs; no published oral-specific human PK data) |
Vendors selling Pentadecapeptide BPC (Oral)
| Vendor | Size | Price | Listed purity | Trust |
|---|---|---|---|---|
| Skye Peptides | — | $89.00 | — | 90 |
| Crystal Peptides | — | $74.00 | — | 66 |
| NG Peptide | — | $120.00 | — | — |
| Ruo Bio | — | $68.00 | — | — |
Research
PCO-02 - Safety and Pharmacokinetics Trial
· ClinicalTrials.gov (2015) · rct
Phase I clinical trial in healthy volunteers to study safety and pharmacokinetics of BPC-157, a pentadecapeptide from gastric source.
source →